HAUPPAUGE, N.Y., USA: Crosstex has entered into a definitive agreement with North American Science Associates (NAMSA) to acquire its Sterility Assurance Monitoring Products division. This division manufactures a broad suite of high-quality biological and chemical indicators which are used to accurately monitor the effectiveness of sterilization processes. These indicators are designed primarily for the industrial segment serving medical device, life science and other manufacturers, representing a new end-market for Crosstex.
Gary Steinberg, president and CEO of Crosstex, said, “This acquisition not only allows us to expand our sterility assurance product offering, but also broadens our presence into the important industrial market segment. We are also excited to provide additional product solutions to these customers with Crosstex’s complete infection prevention product portfolio.”
John Hughes, vice president and general manager of Crosstex/SPSmedical in Rochester, N.Y., stated, “The addition of NAMSA’s Sterility Assurance Products Division expands our market position in the biological and chemical integrator market while strengthening our manufacturing capabilities through greater vertical integration.”
Hughes went on to say, “We have retained the sales, marketing and customer care team, which will allow for a seamless transition and provide our new customers with the same level of service and support they have been accustomed to receiving.”
Subject to customary closing conditions, the transaction is expected to close in the third quarter of fiscal year 2016 for Crosstex.
(Source: Crosstex)
Cantel Medical Corp. subsidiary, Crosstex, continues its market diversification and expansion with the acquisition of Accutron Inc., an industry-leading ...
NEW YORK, N.Y., USA: George Taub Products and Fusion Co. Inc., has rebranded to TAUB Products with a new corporate logo and fresh concept marketing for ...
NEW YORK, NY, USA: Danaher Corp. has entered into a definitive agreement to acquire PaloDEx Holding Oy (PaloDEx), a manufacturer of dental imaging products ...
Dental Tribune USA sat down with Maurice Valen, Adj.Prof., founder and CEO of Impladent, to find out more about his life and his career and what is next for...
CHICAGO, IL, USA: Water Street Healthcare Partners announced that it has acquired OraPharma from Johnson & Johnson. Water Street, a strategic private ...
In August, Fotona completed the purchase of the Fox III and Fox IV laser systems and the EmunDo Therapy system from A.R.C. Laser GmbH. This purchase ...
In an interview with Dental Tribune conducted during the recent CDA Presents the Art and Science of Dentistry meeting in San Francisco, DEXIS Sales Regional...
SAN FRANCISCO, CA, USA: The California Dental Association held CDA Presents the Art and Science of Dentistry 10-13 September at Moscone West. In addition to...
NEW YORK, N.Y., and PALM BEACH GARDENS, Fla., USA: Cerberus Capital Management, L.P., known as a global leader in alternative investing, announced that one ...
Live webinar
Mon. 12 January 2026
9:00 AM EST (New York)
Prof. Judith Jones D.D.S; M.P.H., Prof. Kakuhiro Fukai D.D.S., Ph.D, Dr. Bathsheba (Bethy) Turton
Live webinar
Wed. 14 January 2026
12:00 PM EST (New York)
Dr. Théo Laplane, Dr. Robert Gottlander DDS
Live webinar
Fri. 16 January 2026
12:00 PM EST (New York)
Live webinar
Mon. 19 January 2026
1:00 PM EST (New York)
Philipp Kopp, Michael Seeber
Live webinar
Thu. 22 January 2026
2:00 PM EST (New York)
Dr. Nicola M. Grande DDS, PhD
Live webinar
Wed. 28 January 2026
8:00 AM EST (New York)
Live webinar
Wed. 28 January 2026
11:00 AM EST (New York)
Prof. Dr. Jan-Frederik Güth
To post a reply please login or register